REPROCELL and Polyphron Collaborate to Advance AI-Driven Human Tissue Research in the U.S.
REPROCELL, a Japanese company, and Polyphron, Inc., based in Long Island City, NY, have announced a collaboration to advance AI-driven human tissue research. REPROCELL will supply its proprietary StemRNA™ iPSCs (induced pluripotent stem cells) for use in Polyphron’s artificial human biology platform. This partnership aims to integrate donor-diverse human iPSCs into Polyphron’s system, facilitating the generation of longitudinal biological data. This data will then be used to train and improve computational models that predict human tissue behavior. Polyphron's Tissue Foundry utilizes automated manufacturing and stem-cell biology to create structured human tissues from various donor backgrounds. These tissues are subjected to controlled interventions and measured over time using multiple biological readouts. The resulting 'tissue trajectories' are crucial for training Polyphron’s Tissue World Models, which are designed to forecast how tissue responds to genetic, chemical, biological, and environmental chang...
